Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323763 · ClinicalTrials.gov registry record
An fMRI Study on Temporal Discounting in Bipolar Disorder
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 28
- Enrollment target
NCT02323763: Completed study, sponsored by Massachusetts General Hospital.
NCT02323763 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02323763 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The investigators propose to explore the link between bipolar disorder, anxiety, and suicide by investigating intertemporal discounting in depressed, suicidal patients with bipolar I and II disorder who have various levels of anxiety. The investigators will determine the effect of anxiety on their intertemporal discounting (small rewards now compared to larger rewards later) in a decision-making paradigm and investigate the associated functional neuroanatomy using functional magnetic resonance imaging (fMRI).
Primary Outcome
Functional Magnetic Resonance Imaging (fMRI) will be used to look at the neuroanatomy of intertemporal discounting in patients with bipolar I and II disorder
Interventions
- OTHER fMRI Scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-07-14 |
| Est. Completion | 2016-08-29 |
What the finished NCT02323763 record still lists
NCT02323763 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which fMRI Scanning is the first listed.
NCT02323763 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02323763 about?
NCT02323763 is a clinical study titled "An fMRI Study on Temporal Discounting in Bipolar Disorder". The investigators propose to explore the link between bipolar disorder, anxiety, and suicide by investigating intertemporal discounting in depressed, suicidal patients with bipolar I and II disorder who have various levels of anxiety. The investigators will determine the effect of anxiety on their i...
What is the current status of trial NCT02323763?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2014-07-14. Estimated completion is 2016-08-29.
What interventions are being tested in trial NCT02323763?
The interventions under investigation include: fMRI Scanning (OTHER).
Who is sponsoring clinical trial NCT02323763?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI